Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.060 AlteredExpression phenotype BEFREE Muscle aches/pain are strongly associated with decreased CRP and IL-8 levels and increased IL-6 levels suggesting the need for further investigation of the biological pathways contributing to pain in PLWH. 31433243 2020
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.030 Biomarker phenotype BEFREE After controlling for sex, menopause stage and body mass index, significant differences were noted in C-reactive protein (CRP), interleukin (IL)-6, and IL-8 for PLWH who reported muscle aches/joint pain. 31433243 2020
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.020 Biomarker phenotype BEFREE After controlling for sex, menopause stage and body mass index, significant differences were noted in C-reactive protein (CRP), interleukin (IL)-6, and IL-8 for PLWH who reported muscle aches/joint pain. 31433243 2020
Entrez Id: 728458
Gene Symbol: OPN1MW2
OPN1MW2
0.010 Biomarker phenotype BEFREE A combination of cannabidiol and tetrahydrocannabinol (CBD/THC) was prescribed as compassionate use to six patients (four patients with myotonic dystrophy types 1 and 2, and 2 patients with CLCN1-myotonia) with therapy-resistant myotonia and myalgia. 31655890 2020
Entrez Id: 1180
Gene Symbol: CLCN1
CLCN1
0.010 Biomarker phenotype BEFREE A combination of cannabidiol and tetrahydrocannabinol (CBD/THC) was prescribed as compassionate use to six patients (four patients with myotonic dystrophy types 1 and 2, and 2 patients with CLCN1-myotonia) with therapy-resistant myotonia and myalgia. 31655890 2020
Entrez Id: 101060233
Gene Symbol: OPN1MW3
OPN1MW3
0.010 Biomarker phenotype BEFREE A combination of cannabidiol and tetrahydrocannabinol (CBD/THC) was prescribed as compassionate use to six patients (four patients with myotonic dystrophy types 1 and 2, and 2 patients with CLCN1-myotonia) with therapy-resistant myotonia and myalgia. 31655890 2020
Entrez Id: 2652
Gene Symbol: OPN1MW
OPN1MW
0.010 Biomarker phenotype BEFREE A combination of cannabidiol and tetrahydrocannabinol (CBD/THC) was prescribed as compassionate use to six patients (four patients with myotonic dystrophy types 1 and 2, and 2 patients with CLCN1-myotonia) with therapy-resistant myotonia and myalgia. 31655890 2020
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.120 GeneticVariation phenotype BEFREE We present three boys with DMD single nucleotide variants associated with Becker muscular dystrophy presenting with myalgia, reduced exercise capacity, neurodevelopmental symptoms and elevated creatine kinase. 31706698 2019
Entrez Id: 84876
Gene Symbol: ORAI1
ORAI1
0.110 GeneticVariation phenotype BEFREE Gain-of-function mutations in STIM1 or ORAI1 isoforms cause tubular aggregate myopathy (TAM), a skeletal muscle disorder with muscular pain, weakness and cramping. 30382595 2019
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.110 Biomarker phenotype BEFREE Muscle soreness and IL-10 were elevated only 48 h after SSC protocol. 30953177 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.060 Biomarker phenotype BEFREE The main effect of condition was detected for IL-6 (SUP: 1.36 ± 0.66 vs CON: 2.06 ± 1.14 pg/ml) (P < 0.05, η<sup>2</sup> = 0.54), sIL-6R (SUP: 27,615 ± 8446 vs CON: 24,368 ± 7806 pg/ml) (P < 0.05, η<sup>2</sup> = 0.41) and muscle soreness (P < 0.01, η<sup>2</sup> = 0.67). 31624951 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.060 Biomarker phenotype BEFREE These results support the hypothesis that IL-6 plays a central role in the induction of muscle pain in HAVS. 31335655 2019
Entrez Id: 4803
Gene Symbol: NGF
NGF
0.050 Biomarker phenotype BEFREE On days 0, 2, and 4, nerve growth factor was injected into the right forearm to induce progressively developing muscle soreness and mechanical hyperalgesia. 31356456 2019
Entrez Id: 4803
Gene Symbol: NGF
NGF
0.050 Biomarker phenotype BEFREE Intramuscular injection of Nerve Growth Factor (NGF) may influence the responsiveness of active chemo-sensitive channels affecting muscle pain sensitivity. 31314952 2019
Entrez Id: 4803
Gene Symbol: NGF
NGF
0.050 GeneticVariation phenotype BEFREE To test whether PAF can provide information about pain sensitivity occurring over clinically relevant timescales (i.e., weeks), EEG was recorded before and while participants experienced a long-lasting pain model, repeated intramuscular injection of nerve growth factor (NGF), that produces progressively developing muscle pain for up to 21 days. 31389754 2019
Entrez Id: 4151
Gene Symbol: MB
MB
0.050 AlteredExpression phenotype BEFREE Changes in maximal voluntary isometric contraction strength (MVC) and muscle soreness, plasma creatine kinase (CK) activity and myoglobin concentration after 80% EC were compared between groups by a mixed-factor ANOVA. 30778759 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.040 Biomarker phenotype BEFREE At baseline, 24 and 48 h, creatine kinase, lactate dehydrogenase, interleukin-6 and -10, tumor necrosis factor alpha, and muscle soreness were assessed. 30471384 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.040 Biomarker phenotype BEFREE In addition, exercise increased the endocannabinoid anandamide levels and cannabinoid CB<sub>2</sub> receptors expression whereas it reduced Iba1 (microglial marker) protein expression as well as pro-inflammatory cytokines (TNF-α and IL-1β) in the spinal cord of mice with inflammatory muscle pain. 31473278 2019
Entrez Id: 9311
Gene Symbol: ASIC3
ASIC3
0.030 Biomarker phenotype BEFREE Asic3<sup>-/-</sup> mice were impaired in only muscle allodynia development but not other pain symptoms in the ICS model, so the ASIC3-dependent metabolomics changes could be useful for developing diagnostic biomarkers specific to chronic widespread muscle pain, the core symptom of FM. 31431652 2019
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.030 Biomarker phenotype BEFREE Anti-interleukin-1 (IL-1) therapy may be a beneficial and a reasonable treatment option, when there is insufficient response to NSAID and corticosteroid therapies in pediatric PFMS patients. 30293156 2019
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.030 Biomarker phenotype BEFREE In addition, exercise increased the endocannabinoid anandamide levels and cannabinoid CB<sub>2</sub> receptors expression whereas it reduced Iba1 (microglial marker) protein expression as well as pro-inflammatory cytokines (TNF-α and IL-1β) in the spinal cord of mice with inflammatory muscle pain. 31473278 2019
Entrez Id: 199
Gene Symbol: AIF1
AIF1
0.020 AlteredExpression phenotype BEFREE In addition, exercise increased the endocannabinoid anandamide levels and cannabinoid CB<sub>2</sub> receptors expression whereas it reduced Iba1 (microglial marker) protein expression as well as pro-inflammatory cytokines (TNF-α and IL-1β) in the spinal cord of mice with inflammatory muscle pain. 31473278 2019
Entrez Id: 199
Gene Symbol: AIF1
AIF1
0.020 AlteredExpression phenotype BEFREE Differently, Iba-1 is downregulated after axotomy but upregulated after partial lesion of peripheral nerve as well as after virus inoculation and during non-inflammatory muscle pain. 31002029 2019
Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
0.010 Biomarker phenotype BEFREE Ovarian Hormone-dependent and Spinal ERK Activation-regulated Nociceptive Hypersensitivity in Female Rats with Acid Injection-induced Chronic Widespread Muscle Pain. 30816240 2019
Entrez Id: 43
Gene Symbol: ACHE
ACHE
0.010 AlteredExpression phenotype BEFREE Acetylcholinesterase (EC3.1.1.7; AChE), an enzyme critical for cholinergic neurotransmission, is abundantly expressed in neurons and mature myotubes, and we recently found that muscle AChE expression was suppressed in parallel with the inhibition of myogenic differentiation upon TCDD treatment in mouse C2C12 cells. 31100272 2019